Introduction

ABSTRACT
There is much evidence that endogenous opioid peptides are involved in the regulation of food and water intake in a variety of species. We report here that the exogenous opiate agonist, butorphanol tartrate (1 ag/kg), significantly increases food, but not water, intake in normal humans.
The major effect on food intake was seen within the first 2 h after the administration of drug, These findings suggest that this drug may be therapeutically useful in patients with cancer anorexia.
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Results and discussion
Nine of the 10 subjects increased their calorie intake on the day they received butorphanol compared to the day they received saline (Fig I, p <0 .01).
One subject decreased food intake after butorphanol.
The increase in food intake following butorphanol was blocked by the concomitant administration of naloxone (p <0.05). Although mean water intake increased on the butorphanol treatment day (1215 ± 182 ml/6 h) compared to the saline day (976 ± 169 ml/6 h), the increase was not significant and may be related to the increase in food intake.
Similarly, the water intake after combined butorphanol and naloxone administration (1047 ± 157 ml/6 h) was not significantly reduced compared to the day on which the subjects received butorphanol alone. There were no significant differences in the subjective feelings of hunger as measured by the satiety analog scale between any of the treatment groups (Table I ). This would be in keeping with the report that naloxone fails to alter the perception of hunger in normal individuals (25) .
As it has been reported that opiate agonists and antagonists may modulate macronutrient preference (26, 27), and we have preliminary 
